Faster-acting insulin aspart vs insulin aspart as part of basal-bolus therapy improves postprandial glycaemic control in uncontrolled Type 2 diabetes in the double-blinded onset 2 trial

被引：0
|
作者：
Saravanan, P. [1 ,2 ]
Bowering, K. [3 ]
Case, C. [4 ]
Harvey, J. [5 ]
Reeves, M. [6 ]
Sampson, M. [7 ]
Strzinek, R. [8 ]
Bretler, D. M. [9 ]
Bang, R. B. [10 ]
Bode, B. W. [11 ]
机构：
[1] Univ Warwick, Diabet Endocrinol & Metab, Coventry, W Midlands, England
[2] George Eliot Hosp, Coventry, W Midlands, England
[3] Univ Alberta, Dept Med, Edmonton, AB, Canada
[4] Jefferson City Med Grp, Endocrinol, Jefferson City, MO USA
[5] Bangor Univ, Wrexham Acad Unit, Bangor, Gwynedd, Wales
[6] Diabet Clin Trials, Chattanooga, TN USA
[7] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwich, Norfolk, England
[8] Protenium Clin Res, Hurst, TX USA
[9] Novo Nordisk AS, Global Dev, Soborg, Denmark
[10] Novo Nordisk AS, Biostat & Clin Reporting, Soborg, Denmark
[11] Atlanta Diabet Associates, Atlanta, GA USA
来源：
DIABETIC MEDICINE | 2017年 / 34卷
关键词：
D O I：
10.1111/dme.29_13304
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A46
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] Faster-acting insulin aspart vs insulin aspart as part of basal-bolus therapy improves postprandial glycaemic control in uncontrolled type 2 diabetes: the onset® 2 trial
    Bowering, K.
    Case, C.
    Harvey, J.
    Reeves, M.
    Sampson, M.
    Strzinek, R.
    Bretler, D. -M.
    Bang, R. B.
    Bode, B. W.
    DIABETOLOGIA, 2016, 59 : S399 - S400
  • [2] Faster-Acting Insulin Aspart vs. Insulin Aspart as Part of Basal-Bolus Therapy Improves Postprandial Glycemic Control in Uncontrolled T2D in the Double- Blinded Onset® 2 Trial
    Bowering, Keith
    Case, Christopher
    Harvey, John
    Reeves, Michael
    Sampson, Mike
    Strzinek, Robert
    Bretler, Ditte-Marie
    Bang, Rikke Beck
    Bode, Bruce W.
    DIABETES, 2016, 65 : A63 - A63
  • [3] Double-blind mealtime faster-acting insulin aspart vs insulin aspart in basal-bolus improves glycaemic control in Type 1 diabetes: the onset 1 trial
    Russell-Jones, D.
    Bode, B. W.
    De Block, C.
    Franek, E.
    Heller, S.
    Mathieu, C.
    Philis-Tsimikas, A.
    Rose, L.
    Woo, V.
    Osterskov, A. B.
    Graungaard, T.
    Bergenstal, R.
    DIABETIC MEDICINE, 2017, 34 : 8 - 8
  • [4] Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial
    Bowering, Keith
    Case, Christopher
    Harvey, John
    Reeves, Michael
    Sampson, Michael
    Strzinek, Robert
    Bretler, Ditte-Marie
    Bang, Rikke Beck
    Bode, Bruce W.
    DIABETES CARE, 2017, 40 (07) : 951 - 957
  • [5] Double-Blind Mealtime Faster-Acting Insulin Aspart vs. Insulin Aspart in Basal-Bolus Improves Glycemic Control in T1D: The Onset® 1 Trial
    Russell-Jones, David
    Bode, Bruce W.
    De Block, Christophe
    Franek, Edward
    Heller, Simon R.
    Mathieu, Chantal
    Philis-Tsimikas, Athena
    Rose, Ludger
    Woo, Vincent C.
    Osterskov, Anne Birk
    Graungaard, Tina
    Bergenstal, Richard
    DIABETES, 2016, 65 : A77 - A77
  • [6] IMPROVED POSTPRANDIAL GLYCAEMIC CONTROL WITH FASTER-ACTING INSULIN ASPART VS INSULIN ASPART IN SUBJECTS WITH TYPE 1 DIABETES USING CSII IN PUMPS
    Bode, B. W.
    Hyveled, L.
    Tamer, S. C.
    Demissie, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A40 - A40
  • [7] Double-blind mealtime faster-acting insulin aspart improves glycaemic control with superior reduction in postprandial glucose excursions vs insulin aspart in type 1 diabetes: onset® 1
    Russell-Jones, D.
    Bode, B. W.
    De Block, C.
    Franek, E.
    Heller, S.
    Mathieu, C.
    Philis-Tsimikas, A.
    Rose, L.
    Woo, V.
    Osterskov, A. B.
    Graungaard, T.
    Bergenstal, R. M.
    DIABETOLOGIA, 2016, 59 : S6 - S6
  • [8] Adding faster-acting insulin aspart to basal insulin significantly improved glycaemic control in adults with Type 2 diabetes: the onset 3 trial
    Saravanan, P.
    Rodbard, H.
    Tripathy, D.
    Velazquez, M. V.
    Demissie, M.
    Tamer, S. Can
    Piletic, M.
    DIABETIC MEDICINE, 2017, 34 : 69 - 69
  • [9] Adding faster-acting insulin aspart to basal insulin significantly improved glycaemic control in adults with type 2 diabetes: the onset® 3 trial
    Piletic, M.
    Tripathy, D.
    Velazquez, M. Vidrio
    Demissie, M.
    Tamer, S. Can
    Rodbard, H.
    DIABETOLOGIA, 2016, 59 : S400 - S400
  • [10] Faster-acting insulin aspart improves postprandial glycaemia versus insulin aspart in patients with type 1 diabetes mellitus
    Heise, T.
    Haahr, H.
    Jensen, L.
    Erichsen, L.
    Hompesch, M.
    DIABETOLOGIA, 2014, 57 : S57 - S57
12345